Flippin
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TEA PARTY = FREEDOM OF CHOICE AEGY!!
VFIN = BIG GOVERNMENT CAP ON THE INVESTORS HELPING AN EMERGING COMPANY
Got me some weed! Pharmajanes.com
When can I order! AEGY!
Rand Paul/Tea Party support AEGY / freedom of choice!!
Therapy Cells, Inc. (PINKSHEETS: TCEL) FULL REPORT 1/31/2014
The company’s new approach to cell growth has already been applied to the repair of tendons and joints. The technology has also been applied to the re-growth of pancreas and heart tissue. Rejection does not occur as the new cells are from that individual and are recognized by the body as non foreign. It is believed that this new method of cell growth will be successfully used for cell and organ repair in many parts of the human body.
Therapy Cells has developed a novel and highly efficient method of growing tendon and articular cartilage for auto transplantation into individual, affected patients. The company has developed new cell theory that dispenses with the notion that cells cannot divide once they are fully mature. TCEL has shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory.
Therapy Cell has developed a methodology that allows adult cells to divide and grow in controlled laboratory conditions. These new cells can then be used for transplantation back to damaged tissue to enact tissue and organ healing.
To date, the technology has been used for the growth and transplantation of:
Tendons and ligaments and Articular cartilage They have also applied this technology to successfully grow pancreatic cells, for treatment of diabetes, and cardiac cells for the treatment of heart disease, as well as other cell types from many other tissues.
Therapy Cells has shown that given the right culture conditions, these cell types can be grown into millions of new cells, and then successfully transplanted back into the injured tissue of the individual who has donated the cells, leading to tissue repair with one’s one cells.
The need for tissue and organ repair is growing. This is due to the continual growth of our population, coupled with individual needs to maintain good health. And, as our population grows, so does the number of older people seeking to maintain optimal activity levels
This is a steal at this price....although I wish I would have got out and in I'm holding
TCEL - The Inside Scoop
We've been closely monitoring TCEL as new information about this stock comes in.
Capital Equity Report is constantly locating, watching, and alerting our subscribers about TCEL and other key stocks.
If you would like to get these alerts on TCEL and additional information on stocks that are about to breakout, subscribe to our FREE mailing list for up to date news and alerts.
THERAPY CELLS INC (TCEL) – 0.0042
Last Trade: 0.0042
Trade Time: 3:33pm
Change: -0.0005 (-10.64%)
Prev Close: 0.0047
Open: 0.0036
Bid: N/A
Ask: 0.0047
Day's Range: 0.0024 - 0.0065
52wk Range: 0.0007 - 0.51
Volume: 6322103
Avg Vol: 1442760
Market Cap: 4K
P/E (ttm): N/A
PES (ttm): -0.341
2400%<TCEL=Revolutionary$30M+patent
( 1 of 1 )
United States Patent 8,372,644
Casey , et al. February 12, 2013
Method for growing adult cells
Abstract
A method for growing adult cells includes harvesting a tissue sample from a subject and breaking the tissue sample into fragments. The fragments are placed into a culture vessel, and at least some of the fragments are induced to adhere to the culture vessel. The fragments are supplied with nutrients so that adult cells contained therein divide and grow.
Inventors:
Casey; Patrick J. (Kumeu, NZ), Fry; Richard (Kumeu, NZ), Fry; Kerri (Kumeu, NZ)
Applicant:
Name
City
State
Country
Type
Casey; Patrick J.
Fry; Richard
Fry; Kerri
Kumeu
Kumeu
Kumeu
N/A
N/A
N/A
NZ
NZ
NZ
Assignee:
Transplantation Limited (Kumeu, NZ)
Family ID:
38919541
Appl. No.:
11/702,895
Filed:
February 6, 2007
Prior Publication Data
Document Identifier
Publication Date
US 20080009059 A1 Jan 10, 2008
Related U.S. Patent Documents
Application Number
Filing Date
Patent Number
Issue Date
60765668 Feb 6, 2006
Current U.S. Class: 435/379 ; 435/380; 435/381; 435/395
Current CPC Class: C12N 5/00 (20130101)
Current International Class: C12N 5/00 (20060101)
References Cited [Referenced By]
U.S. Patent Documents
7022518 April 2006 Feye
Foreign Patent Documents
WO 0146401 Jun 2001 WO
Primary Examiner: Ketter; Jim
Attorney, Agent or Firm: Preti Flaherty Beliveau & Pachios LLP
Parent Case Text
CROSS REFERENCES TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No. 60/765,668, filed Feb. 6, 2006.
Claims
What is claimed is:
1. A method for growing adult cells comprising: harvesting a tissue sample from a subject; breaking the tissue sample: into fragments; placing the fragments into a culture vessel; inducing at least some of the fragments to adhere to the culture vessel by the steps of: placing the fragments into the culture vessel; adding enough media to keep the fragments moist but not suspended; flipping the culture vessel over; and incubating the fragments; and supplying the fragments with nutrients so that adults cells contained therein divide and grow.
2. The method of claim 1 wherein supplying the fragments with nutrients includes immersing the fragments in a cell culture media.
3. The method of claim 2 wherein said cell culture media is bicarb DMEM/F12+10% FCS.
4. The method of claim 1 wherein incubating the fragments includes placing the culture vessel in a 5% CO.sub.2/38.5 degree Celsius incubator.
5. The method of claim 4 wherein the culture vessel is left in the 5% CO.sub.2/38.5 degree Celsius incubator for about 48 hours.
6. The method of claim 1 wherein breaking the tissue sample into fragments includes dissection.
7. The method of claim 1 wherein breaking the tissue sample into fragments includes chemical digestion.
8. The method of claim 1 wherein breaking the tissue sample into fragments includes physical digestion.
9. The method of claim 1 further comprising removing cells from the culture vessel after cell growth is about 90% confluent.
10. The method of claim 9 wherein cells are removed via Trypsin/EDTA digestion.
Description
BACKGROUND OF THE INVENTION
It is well known that many animal and plant cells may be grown in vitro. However, certain cells, particularly adult or non-embryonic cells, are severely limited in their ability to divide and grow. Cellular growth is not limited by genetic models of memory. Instead, cellular growth is limited by "spatial compaction." For example, organs stop growing due to pressure from the peri or covering material of the organ.
Accordingly, it would be desirable to develop methodologies for processing non-embryonic cells so that the cells grow and divide unimpeded as if they were embryonic cells.
SUMMARY OF THE INVENTION
The above-mentioned need is met by the present invention, one embodiment of which includes a method for growing adult cells that includes harvesting a tissue sample from a subject and breaking the tissue sample into fragments. The fragments are placed into a culture vessel, and at least some of the fragments are induced to adhere to the culture vessel. The fragments are supplied with nutrients so that adult cells contained therein divide and grow.
The present invention and its advantages over the prior art will be more readily understood upon reading the following detailed description.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to an in vitro method for growing adult cells from a tissue sample taken from a mammal or other organism. Adult cells grown under specific culture conditions reach confluence and then form structures related to the origin of the cell type. For example, cells originating from an equine nucal ligament can form tendon-like structures in vitro. Other examples include, but are not limited to, porcine pancreatic tissue and articular cartilage. While the present invention is particularly applicable to eutherian and marsupial mammals, it should be noted that the present invention is not limited to mammalian cells. The present invention is also not necessarily limited to structures commonly recognized as organs.
In general, the method comprises harvesting a tissue sample from a patient and breaking the tissue sample down into fragments. The fragments are placed in a culture vessel and induced to attach or adhere to the vessel. Adherence to the vessel will allow the cells to grow and divide. The attached tissue fragments are then supplied with nutrients (for example, but not limited to, immersion in specific cell culture media under predetermined conditions) to induce the proliferation of cells. After a number of cell doublings, the cells can be harvested, packaged and administered back to the patient, thus providing cells of the correct type that avoid rejection.
The tissue sample is typically harvested aseptically and then washed once in PBS (phosphate buffered saline)/PenStrep (penicillin-streptomycin) solution. The tissue sample is then placed in media (e.g., hepes DMEM/F12+10% FCS+PenStrep) at room temperature for transport to the lab. The tissue sample may be processed immediately or kept for a period of time (typically up to 24 hours) at an appropriate temperature, such as 4 degrees Celsius, before processing.
The tissue sample may be fragmented by any suitable technique, including but not limited to dissection, chemical digestion, and physical digestion. Moreover, the tissue fragments may be attached to the vessel using any suitable technique, such as those described below.
When cell growth is about 90% confluent in the culture vessel, cells are removed via Trypsin/EDTA digestion. The cells are counted using a haemocytometer and the suspension then centrifuged. The cells may be frozen or used for therapeutic administration.
For therapeutic samples (e.g., equine tendon), the resulting pellet is re-suspended in about 0.5 ml of PBS and loaded into a 1 ml syringe. The syringe is transported back to patient at room temperature and the suspension administered back to the patient.
EXAMPLES
Dissection
In this example, a tissue sample, such as from equine articular cartilage or porcine pancreatic tissue, is harvested and washed as described above and placed in 2 ml of Media 1 (hepes DMEM/F12+10% FCS+PenStrep) in a glass petri dish. The tissue sample is then dissected into 2.times.2 mm pieces using sterile scalpel blades. The pieces or fragments are then placed into a 25 ml tissue culture flask with only enough media to keep tissue moist, not suspended. This flask is then flipped over (or partially tipped) and 2 ml of Media 1 is added to the bottom to keep the tissue fragments humidified. With the flask inverted, the fragments are stressed by gravity but tend to remain in contact with the flask surface due to the moisture from the media. The flask is then placed in a 5% CO.sub.2/38.5 degree Celsius incubator for 48 hours. During this time, some of the tissue fragments will adhere to the flask surface. After 48 hours, the humidifying media is removed, the flask is flipped upright, and 2 ml of Media 2 (bicarb DMEM/F12+10% FCS) is gently added to bathe and immerse the tissue fragments. Cell growth from the tissue fragments is monitored daily, and media is replaced every 2-3 days. When cell growth is confluent around the tissue fragments, the media is removed and the culture is washed with PBS/PenStrep. The cells are then harvested via Trypsin/EDTA incubation. When most of the cells have detached from the flask surface, the digestion is stopped with the addition of 5-10 mls Media 2. The suspension is then aspirated to break up cell aggregates and then centrifuged. The resulting pellet is re-suspended in Media 2 and the suspension placed in a 75 or 150 ml flask to scale-up cell numbers rapidly.
Chemical Digestion
In this example, a tissue sample, such as from equine articular cartilage or porcine pancreatic tissue, is harvested and washed as described above and placed in 2 ml of Media 1 in a glass petri dish. The tissue sample is then dissected into 2.times.2 mm pieces using sterile scalpel blades. The pieces or fragments are then incubated with Trypsin/EDTA. The cellular fragments resulting from this incubation are harvested via centrifugation, re-suspended in 2 ml of Media 1, and then placed into a 25 ml tissue culture flask. This flask is then flipped over (or partially tipped), and the 2 ml of Media 1 keep the tissue fragments humidified. With the flask inverted, the fragments are stressed by gravity but tend to remain in contact with the flask surface due to the moisture from the media. The flask is then placed in a 5% CO.sub.2/38.5 degree Celsius incubator for 48 hours. During this time, some of the tissue fragments adhere to the flask surface. After 48 hours, the humidifying media is removed, the flask is flipped upright, and 2 ml of Media 2 is gently added to bathe and immerse the tissue fragments. Cell growth from the tissue fragments is monitored daily, and media is replaced every 2-3 days. When cell growth is confluent around the tissue fragments, the media is removed and the culture is washed with PBS/PenStrep. The cells are then harvested via Trypsin/EDTA incubation. When most of the cells have detached from the flask surface, the digestion is stopped with the addition of 5-10 mls Media 2. The suspension is then aspirated to break up cell aggregates and then centrifuged. The resulting pellet is re-suspended in Media 2 and the suspension placed in a 75 or 150 ml flask to scale-up cell numbers rapidly.
Physical Digestion
In this example, a tissue sample, such as from equine articular cartilage or porcine pancreatic tissue, is harvested aseptically. Small pieces of the tissue are forced through a sterile metal sieve. The resulting fragments are washed in a PBS/PenStrep solution and centrifuged three times. The resulting pellet is re-suspended in 2 ml of Media 1 and then placed into a 25 ml tissue culture flask. This flask is then flipped over (or partially tipped), and the 2 ml of Media 1 keep the tissue fragments humidified. With the flask inverted, the fragments are stressed by gravity but tend to remain in contact with the flask surface due to the moisture from the media. The flask is then placed in a 5% CO.sub.2/38.5 degree Celsius incubator for 48 hours. During this time, some of the tissue fragments adhere to the flask surface. After 48 hours, the humidifying media is removed, the flask is flipped upright, and 2 ml of Media 2 is gently added to bathe and immerse the tissue fragments. Cell growth from the tissue fragments is monitored daily, and media is replaced every 2-3 days. When cell growth is confluent around the tissue fragments, the media is removed and the culture is washed with PBS/PenStrep. The cells are then harvested via Trypsin/EDTA incubation. When most of the cells have detached from the flask surface, the digestion is stopped with the addition of 5-10 mls Media 2. The suspension is then aspirated to break up cell aggregates and then centrifuged. The resulting pellet is re-suspended in Media 2 and the suspension placed in a 75 or 150 ml flask to scale-up cell numbers rapidly. This methods works well for organs that secrete enzymes and are likely to attract infection when processed via Dissection.
While specific embodiments of the present invention have been described, it should be noted that various modifications thereto can be made without departing from the spirit and scope of the invention as defined in the appended claims.
* *
YEAH! ONVO...going up tomorrow again! This is the best flippin stock EVER!!!
if we close at 6 or better a massive surge will commence tomorrow a.m.
ANTRIM CO. -- Veterinarians across the country now have a way to improve the lives of their patients by using a tool to combat osteoarthritis. On Thursday, one dog made history and became the first animal in northern Michigan to receive the treatment.
The technique is called adipose derived cell therapy (OTC:TCEL) allows doctors to take cells from one part on an animal to help repair another part. The technique has been around for a number of years but leaders say it has only just started to take flight across the country in different clinics.
A more than 10-year-old Labrador Mix from Ellsworth named Moka, had the procedure done at North Country Veterinary. Moka was found abandoned in 2011 and taken in by "With a Little Help From My Friends," an Antrim County pet crisis center. Moka struggles to walk and sit on a daily basis because of her painful arthritis in her hips.
"We take fat cells from a patient, isolate the stem cells which are the body's own healing cells," said Doctor Chris Randall. "We take these and activate them, concentrate them, and re-inject them into the patient's injured or diseased area."
"When we put these cells into those joint capsules, I'm confident we'll see great results within a couple of months and she'll be walking around like she's two or three years younger," said Trey Smith, Director of Lab Services for MediVet America.
The procedure starts with doctors removing a few teaspoons of fat tissue from the patient. Moka had some removed near her shoulder blade. A blood sample is also taken that is later transformed into platelet rich plasma (PRP) and is mixed with the regenerated stem cells.
"So the stem cells are cells that are in most of the body's tissues and they're the body's own healing cells," said Dr. Randall. "They are called stem cells because after they are awakened so to speak, they can become any type of cells that are needed by the body."
When the blood and tissues are removed and mixed up, the fat tissue goes into a water bath set at approximately 98.6 degrees Fahrenheit. The blood is placed into a machine where it spins around and separates into two layers of plasma and red blood cells. The plasma is removed and then spun again and separated from the PRP.
Several hours later, Moka's hips were injected with the hundreds of millions of regenerative stem cells. They then travel to the area that needs repaired, and will hopefully heal her arthritis. Any extra stem cells were put into Moka's IV bag.
It will take a few months for Moka's healing process to be complete.
Doctor's say the procedure is very natural because it takes already existing cells, places them in a part of the body where they are needed, and speeds up the process of what the body can already do. It is used on dogs, cats, and horses across the country, and costs about the same that a couple years worth of medications for an animal would.
According to MediVet America, 99-percent of the canines in a study showed improvement in one or more of three categories: pain, lameness, and range of motion.
Leaders say it's used on people outside of the country already, and that it could one day become legal in the U.S..
"Going down the road 15, 20 years, this can kind of be a basis for use in human medicine," said Dr. Casey.
TCEL = .10
Right 30 million!! That takes us to 10 cents right there....but...does therapy cells inc. own the patent....or are they given exclusive rights through the patent holder to use? Either way where is this doctor right now??? I want someone on the horn
somebody should look up that patent and post it
what a rush! BBC is broadcasting this new buzz about stem cell therapy based on some "new" findings of Japanese scientists impending this is a revolution in stem cell research.....what this sounds like is PATENT INFRINGEMENT? IDK I'm scouring the web trying to locate this Dr. of therapy cells....some things look real fishy.....but I love to fish.....and drink beer.....and make money!!! TCEL ...if nothing else it may be another BITC(f)
Oh sweet I got scammed again
DUDES! This was just on NPR NEWS or BBC RADIO...also...in my sweet little northern Michigan town this made HEADLINES At the veterinary clinic....I have not made the link between therapy cells and all this BUZZZZZ but I did throw a minor position down just in case still doin DD...in this a schamm or what guys????
This looks hot....http://www.upnorthlive.com/news/story.aspx?id=998142#.UuiQtBEo7mQ.........somebody read that article and tell me if that patent, and this procedure is related? There is news out but does this patent cover all that....or is it just for humans...which would still be phenomenal....this could go to .30 cents before any clinical trials
yes they are photos of pv-10 at work. Remarkable. This is why the FDA is going to approve without phase 3. NO side effects. This guy doesn't look like a mouse to me. All this debate over a news article created an excellent buying opportunity. I'm in. PVCT is going up. Hopefully $2.33 or better on volume of 3m+ tomorrow as more longs decipher through the jargon? A gues of what could as the charts looking for the swing up
dudes! DuPont is going to put an offer on Cereplast! or am I bull ishing
I just bought in....interesting to see
I'll bid .0001 on this pos
off to $2.33 then $3.00 !! PVCT
anyone here from the low triple 0 days? congratulations!
volume lower? I don't think so
1.99 new resistance
RSI + MOMENTUM crossing here we're going up!!!
RSI + MOMENTUM crossing here we're going up!!!
RSI + MOMENTUM crossing here we're going up!!!
we're going to 2.10
I like that. Base forming....if true....your on your way to wealth my friend. I'm with you on PPJE. I forget it, and exhibit patience. Never to rely. Only to learn. Wealth has been created quicker elsewhere. I am negative in PPJE. MY LESSON: SET YOUR STOP LOSS CLOSE TO YOUR BID. LOSE COMMISIONS (no spellcheck?). NOT PERCENTAGES. THAT'S HOW YOU KNOW YOU ARE THE FOUNDATION. Grow and prosper my friend.
MY lesson: PHOT 101. smoke pot watch the hot so you don't have to P. HOT. better yet.........join the Tea Party and be free from the manipulators
Our voters today.
for the long run
No silly bot some....they bot some got some lost some oops umm looks like a shish runn glad I didn't get sum
2 words. Never Again.